Effects of interleukin-1 receptor antagonist on collagen and matrix metalloproteinases in stress-shielded achilles tendons of rats

Orthopedics

Volumn 35, Issue 8, 2012, Pages

  Ma, Yanhong ^a   Yan, Xiaoyan ^a   Zhao, Huakun ^a   Wang, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERSTITIAL COLLAGENASE; PHOSPHATE BUFFERED SALINE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACHILLES TENDON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DETERIORATION; DRUG MECHANISM; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EXPERIMENTAL DENERVATION; MALE; MORPHOLOGY; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; STRESS SHIELDING; TENDON STRESS; TRANSMISSION ELECTRON MICROSCOPY;

ACHILLES TENDON; ANIMALS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; INJECTIONS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84865289589     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120725-26     Document Type: Article

References (37)

1. Noyes FR. Functional properties of knee ligaments and alterations induced by immobilization: a correlative biomechanical and histological study in primates. Clin Orthop Relat Res. 1977; (123):210-242.
2. Yamamoto E, Hayashi K, Yamamoto N. Mechanical properties of collagen fascicles from stress-shielded patellar tendons in the rabbit. Clin Biomech (Bristol, Avon). 1999;14(6):418-425.
3. Uchida H, Tohyama H, Nagashima K, et al. Stress deprivation simultaneously induces over-expression of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta in fibroblasts and mechanical deterioration of the tissue in the patellar tendon. J Biomech. 2005; 38(4):791-798.
4. Wang W, Tang X, Zhang J, Yan X, Ma Y. Complete stress shielding of the Achilles tendon: ultrastructure and level of interleukin-1 and TGF-beta. Orthopedics. 2010; 33(11):810.
5. Thampatty BP, Li H, Im HJ, Wang JH. EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment. Gene. 2007; 386(1-2):154-161.
6. Yang G, Im HJ, Wang JH. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene. 2005; 363:166-172.
7. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002; 13(4-5):323-340.
8. Kuek A, Hazleman BL, Ostör AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007; 83(978):251-260.
9. Nixon R, Bansback N, Brennan A. The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. Rheumatology (Oxford). 2007; 46(7):1140-1147.
10. Moltó A, Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine. 2010; 77(2):102-107.
11. Nigrovic PA, Mannion M, Prince FH, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis:report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011; 63(2):545-555.
12. Zhang B, Hu J, Man C, Zhu S. Effect of intra-articular administration of interleukin 1 receptor antagonist on cartilage repair in temporomandibular joint. J Craniofac Surg. 2011; 22(2):711-714.
13. Ikonomidis I, Lekakis JP, Nikolaou M, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008; 117(20):2662-2669.
14. Kim DH, Lee SH, Kim KT, et al. Association of interleukin-1 receptor antagonist gene polymorphism with response to conservative treatment of lumbar herrniated nucleus pulposus. Spine. 2010; 35(16):1527-1531.
15. Fredberg U, Ostgaard R. Effect of ultrasound-guided, peritendinous injections of adalimumab and anakinra in chronic Achilles tendinopathy: a pilot study. Scand J Med Sci Sports. 2009; 19(3):338-344.
16. Miyatake S, Tohyama H, Kondo E, et al. Local administration of interleukin-1 receptor antagonist inhibits deterioration of mechanical properties of the stress-shielded patellar tendon. J Biomech. 2008; 41(4):884-889.
17. Palmes D, Spiegel HU, Schneider TO, et al. Achilles tendon healing: long-term biomechanical effects of postoperative mobilization and immobilization in a new mouse model. J Orthop Res. 2002; 20(5):939-946.
18. Arner EC, Harris RR, DiMeo TM, Collins RC, Galbraith W. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J Rheumatol. 1995;22(7):1338-1346.
19. Majima T, Yasuda K, Fujii T, et al. Biomechanical effects of stress shielding of the rabbit patellar tendon depend on the degree of stress reduction. J Orthop Res. 1996;14(3):377-383.
20. Amiel D, Akeson WH, Harwood FL, Frank CB. Stress deprivation effect on metabolic turnover of the medial collateral ligament collagen. A comparison between nine- and 12-week immobilization. Clin Orthop Relat Res. 1983; (172):265-270.
21. Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002; 21(2):185-195.
22. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol. 2005;37(2):283-288.
23. Balbin M, Fueyo A, Knäuper V, et al. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem. 2001; 276(13):10253-10262.
24. Mori N, Majima T, Iwasaki N, et al. The role of osteopontin in tendon tissue remodeling after denervation-induced mechanical stress deprivation. Matrix Biol. 2007; 26(1):42-53.
25. Knäuper V, López-Otin C, Smith B, et al. Biochemical characterization of human collagenase-3. J Biol Chem. 1996; 271(3):1544-1550.
26. Lo IK, Marchuk LL, Hollinshead R, et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med. 2004; 32(5):1223-1229.
27. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum. 2006; 54(3):832-842.
28. de Mos M, van El B, DeGroot J, et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med. 2007; 35(9):1549-1556.
29. Lakemeier S, Schwuchow SA, Peterlein CD, et al. Expression of matrix metalloproteinases 1, 3, and 9 in degenerated long head biceps tendon in the presence of rotator cuff tears: an immunohistological study. BMC Musculoskelet Disord. 2010; 11: 271.
30. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-573.
31. Wong WR, Kossodo S, Kochevar IE. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels. J Formos Med Assoc. 2001; 100(6):377-382.
32. Tsuzaki M, Guyton G, Garrett W, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003; 21(2):256-264.
33. Cao Z, Li C, Zhu G. Inhibitory effects of baicalin on IL-1beta- induced MMP-1/TIMP-1 and its stimulated effect on collagen-I production in human periodontal ligament cells. Eur J Pharmacol. 2010;641(1):1-6.
34. Majima T, Yasuda K, Tsuchida T, et al. Stress shielding of patellar tendon: effect on small-diameter collagen fibrils in a rabbit model. J Orthop Sci. 2003; 8(6):836-841.
35. Yin BL, Hao H, Wang YY, et al. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells. Inflamm Res. 2009; 58(2):67-73.
36. Shimizu S, Okuda N, Kato N, et al. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Arthritis Rheum. 2010;62(5):1329-1337.
37. Arruda EM, Mundy K, Calve S, et al. Denervation does not change the ratio of collagen I and collagen III mRNA in the extracellular matrix of muscle. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R983-R987.